ImageneBio Stock Price, News & Analysis
IMA
NASDAQ
Company Description
Welcome to the overview page for ImageneBio (IMA), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$0
Revenue (TTM)
-$24,779,000
Net Income (TTM)
-$2.91
-$26,642,000
Operating Cash Flow
13.24
-$26,594,000
Upcoming Events
OCT
01
October 1, 2026 - December 31, 2026
Clinical
Phase 2b topline data
Topline data for IMG-007 in atopic dermatitis expected
JAN
01
January 1, 2027 - December 31, 2027
Clinical
Phase 2b ADAPTIVE topline data
Expected topline data from IMG-007 Phase 2b ADAPTIVE trial
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of ImageneBio (IMA)?
The current stock price of ImageneBio (IMA) is $6.9 as of January 12, 2026.
What is the market cap of ImageneBio (IMA)?
The market cap of ImageneBio (IMA) is approximately 77.6M. Learn more about what market capitalization means .
What is the revenue (TTM) of ImageneBio (IMA) stock?
The trailing twelve months (TTM) revenue of ImageneBio (IMA) is $0.
What is the net income of ImageneBio (IMA)?
The trailing twelve months (TTM) net income of ImageneBio (IMA) is -$24,779,000.
What is the earnings per share (EPS) of ImageneBio (IMA)?
The diluted earnings per share (EPS) of ImageneBio (IMA) is -$2.91 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of ImageneBio (IMA)?
The operating cash flow of ImageneBio (IMA) is -$26,642,000. Learn about cash flow.
What is the current ratio of ImageneBio (IMA)?
The current ratio of ImageneBio (IMA) is 13.24, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of ImageneBio (IMA)?
The operating income of ImageneBio (IMA) is -$26,594,000. Learn about operating income.